drug · antibody
patient view →margetuximab
Phase 2updated 2mo agoby TerSera Therapeutics LLC🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 1 investigational indication.
targets
Receptor tyrosine-protein kinase erbB-2
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that